GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Statement Of Deviation Or Variation Or Utilization Of Funds Raised Under Preferential Issue - Regulation 32(1) Of SEBI (LODR) Regulations, 2015 For The First Quarter Ended June 30, 2023
Please find attached the statement of Deviation or Variation or utilization of funds raised through preferential issue by the Company for the quarter ended 30th June 2023 GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
please find enclosed press release with respect to un-audited financial results for the quarter ended 30th June 2023 GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Outcome for Outcome Of Board Meeting Held On August 14, 2023
The Board of Directors of the Company, at their meeting held today has inter alia considered and approved Un-audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2023 along with Limited Review Report for the quarter ended June 30, 2023 The meeting of Board commenced at 7.15 p.m. and concluded at 9.20 p.m. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Results- Financial Results For Quarter Ended June 30, 2023
The Board of Directors at its meeting held on August 14, 2023 approved un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2023. The meeting of the Board commenced at 7.15 pm and concluded at 9.20 pm GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Results- Financial Results For Quarter Ended June 30, 2023
The Board of Directors at its meeting held on August 14, 2023 approved un-audited financial results (standalone and consolidated) for the quarter ended 30th June 2023. The meeting of the Board commenced at 7.15 pm and concluded at 9.20 pm GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Board Meeting Intimation for Intimation Of Board Meeting To Approve The Un-Audited Financial Results For The Quarter Ended June 30, 2023
GENESYS INTERNATIONAL CORPORATION LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 ,inter alia, to consider and approve Pursuant to the provisions under Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and other applicable provisions, rules and regulations, if any, this is to inform you that a meeting of the Board of Directors of the Company will be held on Monday, August 14, 2023, to inter alia consider and approve the un-audited financial results (standalone and consolidated) for the quarter ended June 30, 2023. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
The Nomination and Remuneration Committee at its meeting held on July 12, 2023 has approved the allotment of 9,950 equity shares of face value of Rs. 5/- each pursuant to the exercise of the stock options by the eligible employees of the Company under the Genesys ESOP Scheme-2020 and ESOP Scheme-2010. Consequently, post-allotment the paid up capital of the Company shall stand increased to Rs. 18,89,19,320/- divided into 3,77,83,864 equity shares of face value of Rs. 5/- each. These shares shall rank pari-passu with the existing equity shares of the Company in all respects. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
In Compliance with the Regulation 74(5) of SEBI (Depositories and Participants) Reg, 2018, we are enclosing herewith the certificate received from M/s. Bigshare Services limited the Registrar and Share Transfer Agent of the Company for the quarter ended June 30, 2023. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Closure of Trading Window
This is to inform you that as per the Company''s Code of Conduct framed under the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company shall remain closed for all Designated Persons and their immediate relatives from July 01, 2023 till expiry of 48 hours after the declaration of financial results of the Company for the quarter ended June 30, 2023. GENESYS INTERNATIONAL CORPORATION LTD. - 506109 - Intimation To The Holders Of Physical Securities To Furnish PAN, Shareholders KYC Details And Nomination As Per SEBI Circular No. Circular No. SEBI/HO/MIRSD/MIRSD-Pod1/P/CIR/2023/37 Dated March 16, 2023.
We would like to inform you that pursuant to SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD1/P/CIR/2023/37 dated March 16, 2023, our Registrar and Transfer Agent of the Company (RTA) i.e. Bigshare Services Pvt. Ltd., has completed the dispatch of letters intimating the shareholders holding the shares in physical mode, regarding mandatory furnishing of PAN, KYC details and nomination.